Kaleido Biosciences, Inc.·4

Aug 1, 4:31 PM ET

Korn Jerald 4

4 · Kaleido Biosciences, Inc. · Filed Aug 1, 2019

Insider Transaction Report

Form 4
Period: 2019-07-31
Korn Jerald
General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-07-31+180,000180,000 total
    Exercise: $7.67Exp: 2029-07-31Common Stock (180,000 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest on July 22, 2020, with the remaining 75% vesting in equal quarterly installments over the next three years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION